David J. Ellam
Directeur/Bestuurslid bij LyGenesis, Inc.
Oorsprong van het eerstegraads netwerk van David J. Ellam
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 32 | |
| Public Company | Miscellaneous Commercial Services | 16 | |
LyGenesis, Inc.
 LyGenesis, Inc. BiotechnologyHealth Technology LyGenesis, Inc. operates as a biotechnology company. It develops an organ regeneration technology platform enabling a patient's lymph nodes to be used as bioreactors to regrow functioning ectopic organs. The company is headquartered in Pittsburgh, PA.
5
| Holding Company | Biotechnology | 5 |
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met David J. Ellam via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer Treasurer Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Biotechnology | Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Sales & Marketing Chief Tech/Sci/R&D Officer | |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| E-THERAPEUTICS PLC | Biotechnology | Chief Executive Officer Chief Operating Officer Corporate Officer/Principal | |
| ONCOSEC MEDICAL INCORPORATED | Medical/Nursing Services | Director/Board Member | |
Cocoon Biotech, Inc.
 Cocoon Biotech, Inc. BiotechnologyHealth Technology Cocoon Biotech, Inc. develops and manufactures medicines for osteoarthritis patients. The company was founded by Ailis Tweed-Kent in 2013 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Vium, Inc.
 Vium, Inc. Information Technology ServicesTechnology Services Vium, Inc. provides technology for preclinical drug discovery services. It offers biomedical investigators with technology that accelerates the preclinical drug discovery and development pipeline. The company was founded by Timothy L. Robertson and Jonathan Betts-Lacroix in 2013 and is headquartered in San Mateo, CA. | Information Technology Services | Chairman | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Chief Executive Officer Private Equity Investor | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| University of Pennsylvania | College/University | Masters Business Admin Graduate Degree | |
| Imperial College London | College/University | Doctorate Degree Doctorate Degree | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree Masters Business Admin | |
| University of Bristol | College/University | Doctorate Degree Doctorate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| University College London | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
Women in Bio, Inc.
 Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Women in Bio, Inc. is an organization that supports women in the life sciences industry. The non-profit company is based in Bethesda, MD and has subsidiaries in the United States. The organization has 13 chapters in the United States and is funded by sponsors and partners who are dedicated to supporting diversity and inclusion for women of all ages. Founded in 2002, it offers professional educational programs, peer-to-peer learning, mentoring, and networking opportunities for women at all career levels. Women in Bio was founded by Faith L. Charles and Cynthia Wong Hu. | Miscellaneous Commercial Services | Director/Board Member | |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
| PHARNEXT SCA | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
Proteros biostructures GmbH
 Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Medical/Nursing Services | Director of Finance/CFO Chief Executive Officer | |
| ARDELYX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Investor Relations Contact Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Coqual
 Coqual Miscellaneous Commercial ServicesCommercial Services Coqual, formerly known as the Center for Talent Innovation, is a nonprofit think tank that helps leaders create diverse, equitable, and inclusive workplaces. The non-profit company is based in New York, NY, and was founded by Sylvia Ann Hewlett. The company focuses on conducting cutting-edge research and providing advisory services on various identities, including gender, race, ethnicity, disability, veteran status, and LGBTQ. Coqual was founded in 2004 and offers in-depth research, thought leadership, and data-driven solutions to address bias and barriers to inclusion for underrepresented populations in the workplace. Lanaya Irvin has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
| GRITSTONE BIO, INC. | Biotechnology | Director of Finance/CFO Chief Operating Officer | |
Biothera Pharmaceutical, Inc.
 Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | Medical/Nursing Services | Director/Board Member | |
iOX Therapeutics Ltd.
 iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| AVROBIO, INC. | Biotechnology | Director/Board Member | |
| ONCIMMUNE HOLDINGS PLC | Biotechnology | Director/Board Member | |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
| SPRUCE BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Ocean Biomedical, Inc. (United States)
 Ocean Biomedical, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria, Jonathan Kurtis and Jack A. Elias on January 2, 20219 and is headquartered in Providence, RI. | Miscellaneous Commercial Services | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| ACER THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman Founder | |
PhESi LLC
 PhESi LLC Pharmaceuticals: MajorHealth Technology PhESi LLC provides drug and clinical development services for life sciences companies. The private company is based in East Lyme. | Pharmaceuticals: Major | Director/Board Member | |
Thrombolytic Science International LLC
 Thrombolytic Science International LLC Pharmaceuticals: MajorHealth Technology Thrombolytic Science International LLC operates as a vascular medicine and biotech company. The company was founded by Alexis Wallace and Victor Gurewich and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 33 |
| Verenigd Koninkrijk | 11 |
| Canada | 3 |
| Zwitserland | 2 |
| Denemarken | 2 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Health Services | 4 |
| Finance | 4 |
Operationeel
| Director/Board Member | 271 |
| Corporate Officer/Principal | 98 |
| Independent Dir/Board Member | 77 |
| Chairman | 66 |
| Chief Tech/Sci/R&D Officer | 57 |
Sterkste connecties
| Insiders | |
|---|---|
| Jim Mellon | 51 |
| Annalisa Jenkins | 51 |
| Andrew Richards | 44 |
| William Young | 32 |
| Leonard Post | 25 |
| Joseph Klein | 24 |
| Dan Spiegelman | 24 |
| David Solomon | 22 |
| David Lemus | 22 |
| Stephen Aselage | 20 |
| Ken Bate | 19 |
| Lucio Iannone | 17 |
| Sarah Noonberg | 17 |
| Camilla Simpson | 12 |
| Suyash Prasad | 11 |
- Beurs
- Insiders
- David J. Ellam
- Bedrijfsconnecties
